Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Alcon Laboratories Inc.

Division of Alcon Inc.
www.alcon.com

Latest From Alcon Laboratories Inc.

Oculis Raises CHF20M To Advance Topical DME Therapy And Turn Swiss

Icelandic clinical stage biotech Oculis closes CHF20M ($20.3m) series B financing to advance development of its Phase IIb topical DME drug candidate, relocate to Switzerland and beef up its management team.

Companies Financing

US Supreme Court Preview: Cases To Watch For Medtech

A case before the Supreme Court this term will bring the five-year-old PTAB patent examination system into question, while two cases involving are being appealed for review. Of the pending cases, one involves a circuit split on what type of damages consumers must suffer to be allowed to sue medtech companies, while the other looks at the right of states to use outside counsel in suits against manufacturers.

Unlocking Legalities Legal Issues

Novartis Hopes Encore Can Lead To Eye-Watering Presbyopia Success

Novartis is buying a privately-held US company started by an ex-Alcon executive which is developing an eye drop aimed at curing presbyopia, a condition affecting some 80% of people over the age of 45.

Commercial Companies

Gender Discrimination Suits: Cases Against Pharma Continue Even As Payouts Slow

Novartis will pay $8m to settle second case; last year Daiichi Sankyo settled gender discrimination class action for the same amount and action against Bayer was dismissed following confidential resolution. Cases are ongoing against Merck and Forest.

BioPharmaceutical United States
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Ophthalmic
  • Alias(es)
  • Alcon Inc.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Alcon Inc.
  • Senior Management
  • Tim Sear, Pres. & CEO
    Allen Baker, EVP, COO
  • Contact Info
  • Alcon Laboratories Inc.
    Phone: (817) 551-8058
    6201 South Frwy.
    P.O. Box 1959 Fort Worth, TX 76134
    USA
UsernamePublicRestriction

Register